New imaging techniques in the diagnosis of multiple sclerosis

Expert Opinion on Medical Diagnostics

Volumn 2, Issue 9, 2008, Pages 1055-1065

  Fu, Yan ^a   Talavage, Thomas M ^a,b   Cheng, Ji Xin ^a,c  

^a PURDUE UNIVERSITY   (United States)

^b Purdue University   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Coherent anti Stokes Raman scattering microscopy; Magnetic resonance imaging; Multiple sclerosis; Optical coherence tomography

Indexed keywords

GADOLINIUM;

BLOOD BRAIN BARRIER; BRAIN DAMAGE; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT; COHERENT ANTISTOKES RAMAN SCATTERING MICROSCOPY; CONTRAST ENHANCEMENT; CONTRAST SENSITIVITY; CONTROLLED STUDY; DEMYELINATION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE SEVERITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IN VIVO STUDY; MEDICAL TECHNOLOGY; MICROSCOPE; MICROSCOPY; MULTIPLE SCLEROSIS; MYELIN SHEATH; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION DETECTION; RADIOFREQUENCY; RETINA NERVE CELL; REVIEW; SIGNAL DETECTION; THREE DIMENSIONAL IMAGING; VIBRATION;

EID: 77953417397     PISSN: 17530059     EISSN: 17530067     Source Type: Journal    
DOI: 10.1517/17530059.2.9.1055     Document Type: Review

References (83)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221-1231 (Pubitemid 34304266)
2. Bagnato F, Jeffries N, Richert ND, et al. Evolution of T 1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain 2003;126:1782-1789 (Pubitemid 36917337)
3. Brück W, Bitsch A, Kolenda H, et al. Infl ammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783-793 (Pubitemid 27481551)
4. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127 (Pubitemid 32591472)
5. Filippi M, Grossman RI. MRI techniques to monitor MS evolution: the present and the future. Neurology 2002;58:1147-1153 (Pubitemid 34411856)
6. Kallenbach K, Frederiksen J. Optical coherence tomography in optic neuritis and multiple sclerosis: a review. Eur J Neurol 2007;14:841-849
7. Cheng JX. Coherent anti-Stokes Raman scattering microscopy. Appl Spectrosc 2007;61:A197-208
8. Cheng JX, Xie XS. Coherent anti-Stokes Raman scattering microscopy: instrumentation, theory, and applications. J Phys Chem B 2004;108:827-840
9. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005;58:383-391 (Pubitemid 41266624)
10. Wang H, Fu Y, Zickmund P, et al. Coherent anti-Stokes Raman scattering imaging of live spinal tissues. Biophys J 2005;89:581-591 (Pubitemid 41098311)
11. Fu Y, Wang H, Huff TB, et al. Coherent anti-Stokes Raman scattering imaging of myelin degradation reveals a calcium dependent pathway in lyso-PtdCho induced demyelination. J Neurosci Res 2007;85:2870-2881 (Pubitemid 47523571)
12. Van Walderveen MAA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282-1288 (Pubitemid 28240340)
13. Brex PA, Parker GJM, Leary SM, et al. Lesion heterogeneity in multiple slcerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations. J Neurol Neurosurg Psychiatry 2000;68:627-632 (Pubitemid 30248830)
14. Lai M, Hodgson T, Gawne-Cain M, et al. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:339-341 (Pubitemid 26081150)
15. Bakshi R, Ariyaratana S, Benedict RHB, Jacobs L. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol 2001;58:742-748 (Pubitemid 32423046)
16. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol 2005;58:840-846
17. Bink A, Schmitt M, Gaa J, et al. Detection of lesions in multiple sclerosis by 2D FLAIR and single-slab 3D FLAIR sequences at 3.0 T: initial results. Eur Radiol 2006;16:1104-1110
18. Swanton JK, Fernando K, Dalton CM, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006;77:830-833 (Pubitemid 44023177)
19. Rovira A, León A. MR in the diagnosis and monitoring of multiple sclerosis: an overview. Eur J Radiol 2008; published online 21 April 2008
20. Arnold DL, Matthews PM. MRI in the diagnosis and management of multiple sclerosis. Neurology 2002;58:S23-31 (Pubitemid 34411850)
21. Zivadinov R. Can imaging techniques measure neuroprotection and remyelination in multiple sclerosis? Neurology 2007;68:S72-82
22. Traboulsee A, Zhao G, Li DKB. Neuroimaging in multiple sclerosis. Neurol Clin 2005;23:131-148 (Pubitemid 40126918)
23. Rooney WD, Coyle PK. Recent advances in the neuroimaging of multiple sclerosis. Curr Neurol Neurosci Rep 2005;5:217-224 (Pubitemid 40873037)
24. Joy JE, Richard B, Johnston J. Multiple sclerosis: current status and strategies for the future. Washington, DC: National Academy Press; 2001
25. Richards TL. Proton MR spectroscopy in multiple sclerosis: value in establishing diagnosis, monitoring progression, and evaluating therapy. AJR Am J Roentgenol 1991;157:1073-1078
26. Arús C, Chang Y, Bárány M. Proton nuclear magnetic resonance spectra of excised rat brain. Assignment of resonances. Physiol Chem Phys Med NMR 1985;17:23-33
27. Lin A, Ross BD, Harris K, Wong W. Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making. NeuroRx 2005;2:197-214 (Pubitemid 40471432)
28. Matthews PM, de Stefano N, Narayanan S, et al. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol 1998;18:327-336 (Pubitemid 28488949)
29. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991;45:37-45
30. Wolinsky JS, Narayanan S. Magnetic resonance spectroscopy in multiple sclerosis: window into the diseased brain. Curr Opin Neurol 2002;15:247-251 (Pubitemid 34596885)
31. Arnold DL, de Stefano N, Matthews PM, Trapp BD. N-acetylaspartate: usefulness as an indicator of viable neuronal tissue. Ann Neurol 2001;50:823-825
32. Narayanan S. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging 2005;15:S46-57
33. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1996;118:1583-1592
34. De Stefano N, Narayanan S, Francis GS, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001;58:65-70 (Pubitemid 32053209)
35. Lee MA, Blamire AM, Pendlebury S, et al. Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis. Arch Neurol 2000;57:65-70 (Pubitemid 30027632)
36. Gonen O, Catalaa I, Babb JS, et al. Total brain N-acetylaspartate: a new measure of disease load in MS. Neurology 2000;54:15-19 (Pubitemid 30038731)
37. Gonen O, Viswanathan AK, Catalaa I, et al. Total brain N-acetylaspartate concentration in normal, age-grouped females: quantitation with non-echo proton NMR spectroscopy. Magn Reson Med 1998;40:684-689 (Pubitemid 28493644)
38. Ge Y, Gonen O, Inglese M, et al. Neuronal cell injury precedes brain atrophy in multiple sclerosis. Neurology 2004;62:624-627 (Pubitemid 38252807)
39. Chard DT, Griffin CM, McLean MA, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002;125:2342-2352
40. De Stefano N, Filippi M, Miller D, et al. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies. Neurology 2007;69:1942-1952 (Pubitemid 350100353)
41. Wolff S, Balaban RS. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1998;10:135-144
42. Henkelman RM, Huang XM, Xiang QS, et al. Quantitative interpretation of magnetization transfer. Magn Reson Med 1993;29:759-766 (Pubitemid 23182857)
43. Schmierer K, Scaravilli F, Altmann DR, et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004;56:407-415 (Pubitemid 39166560)
44. Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483-491
45. Filippi M, Rocca MA, Martino G, et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809-814 (Pubitemid 28280225)
46. Pike GB, De Stefano N, Narayanan S, et al. Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Neuroradiology 2000;215:824-830 (Pubitemid 30346024)
47. Filippi M, Rocca MA. Magnetization transfer magnetic resonance imaging in the assessment of neurological diseases. J Neuroimaging 2004;14:303-313 (Pubitemid 39331612)
48. Rovaris M, Gass A, Bammer R, et al. Diffusion MRI in multiple sclerosis. Neurology 2005;65:1526-1532 (Pubitemid 41689463)
49. Alexander AL, Lee JE, Lazar M, Field AS. Diffusion tensor imaging of the brain. Neurotherapeutics 2007;4:316-329 (Pubitemid 46962420)
50. Ge Y, Law M, Grossman RI. Application of diffusion tensor MR imaging in multiple sclerosis. Ann NY Acad Sci 2005;1064:202-219 (Pubitemid 43030959)
51. Filippi M, Cercignani M, Inglese M, et al. Diffusion tensor magnetic resonance imaging in mutliple sclerosis. Neurology 2001;56:304-311 (Pubitemid 32144139)
52. Nusbaum AO, Tang CY, Wei TC, et al. Whole-brain diffusion MR histograms differ between MS subtypes. Neurology 2000;54:1421-1427 (Pubitemid 30210459)
53. Cercignani M, Inglese M, Pagani E, et al. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 2001;22:952-958 (Pubitemid 32436241)
54. Castrita Scanderbeg A, Tomaiuolo F, Sabatini U, et al. Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging. AJNR Am J Neuroradiol 2000;21:862-868 (Pubitemid 30262832)
55. Ciccarelli O, Toosy AT, Hickman SJ, et al. Optic radiation changes after optic neuritis detected by tractography-based group mapping. Hum Brain Mapp 2005;25:308-316 (Pubitemid 40911341)
56. Lowe MJ, Horenstein C, Hirsch JG, et al. Functional pathway-defined MRI diffusion measures reveal increased transverse diffusivity of water in multiple sclerosis. Neuroimage 2006;32:1127-1133 (Pubitemid 44278668)
57. Ogawa S, Lee TE, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA 1990;87:9868-9872 (Pubitemid 120016545)
58. Lee M, Reddy H, Johansen-Berg H, et al. The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis. Ann Neurol 2000;47:606-613 (Pubitemid 30261896)
59. Reddy H, Narayanan S, Arnoutelis R, et al. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis. Brain 2000;123:2314-2320 (Pubitemid 30823946)
60. Buckle GJ. Functional magnetic resonance imaging and multiple sclerosis: the evidence for neuronal plasticity. J Neuroimaging 2005;15:S82-93 (Pubitemid 43010534)
61. Frohman EM, Costello F, Zivadinov R, et al. Optical coherence tomography in multiple sclerosis. Lancet Neurol 2006;5:853-863 (Pubitemid 44715820)
62. Ko TH, Fujimoto JG, Duker JS, et al. Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular hole pathology and repair. Ophthalmology 2004;112:1922-1935
63. Parisi V, Manni G, Spadaro M, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalomol Vis Sci 1999;40:2520-2527 (Pubitemid 29455479)
64. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006;113:324-332 (Pubitemid 43170783)
65. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006;59:963-969 (Pubitemid 43830928)
66. Pulicken M, Gordon-Lipkin E, Balcer LJ, et al. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007;69:2085-2092 (Pubitemid 350175711)
67. Gordon-Lipkin E, Chodkowski B, Reich DS, et al. Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 2007;69:1603-1609 (Pubitemid 350287144)
68. Levenson MD, Kano SS. Introduction to nonlinear laser spectroscopy. San Diego: Academic Press; 1988
69. Li L, Wang H, Cheng JX. Quantitative coherent anti-Stokes Raman scattering imaging of lipid distribution in co-existing domains. Biophys J 2005;89:3480-3490 (Pubitemid 41636102)
70. Potma EO, de Boeij WP, van Haastert PJM, Wiersma DA. Real-time visualization of intracellular hydrodynamics in single living cells. Proc Natl Acad Sci USA 2001;98:1577-1582 (Pubitemid 32165541)
71. Zumbusch A, Holtom GR, Xie XS. Three-dimensional vibrational imaging by coherent anti-Stokes Raman scattering. Phys Rev Lett 1999;82:4142-4145 (Pubitemid 129689382)
72. Cheng JX, Volkmer A, Book LD, Xie XS. An epi-detected coherent anti-Stokes Raman scattering (E-CARS) microscope with high spectral resolution and high sensitivity. J Phys Chem B 2001;105:1277-1280 (Pubitemid 32252357)
73. Ganikhanov F, Carrasco S, Xie XS, et al. Broadly tunable dual-wavelength light source for coherent anti-Stokes Raman scattering microscopy. Opt Lett 2006;31:1292-1294 (Pubitemid 43901270)
74. Burkacky O, Zumbusch A, Brackmann C, Enejder A. Dual-pump coherent anti-Stokes Raman scattering microscopy. Opt Lett 2006;31:3656-3658 (Pubitemid 46079733)
75. Cheng JX, Jia YK, Zheng G, Xie XS. Laser-scanning coherent anti-Stokes Raman scattering microscopy and applications to cell biology. Biophys J 2002;83:502-509 (Pubitemid 34694753)
76. Evans CL, Potma EO, Puoris'haag M, Côté D, et al. Chemical imaging of tissue in vivo with video-rate coherent anti-Stokes Raman scattering microscopy. Proc Natl Acad Sci USA 2005;102:16807-16812
77. Huff TB, Cheng JX. In vivo coherent anti-Stokes Raman scattering imaging of sciatic nerve tissue. J Microsc 2007;225:175-182
78. Stewart WA, MacKay AL, Whittall KP, et al. Spin-spin relaxation in experimental allergic encephalomyelitis. Analysis of CPMG data using a non-linear least squares method and linear inverse theory. Magn Reson Med 1993;29:767-775
79. Morell P, Quarles RH. Myelin formation, structure, and biochemistry. In: Siegel GJ, Agranoff BW, Alberts RW, Molinoff PB, editors, Basic neurochemistry: molecular, cellular, and medical aspects. 5th edition. Lippincott Williams & Wilkins, Philadelphia; 1999
80. Regenold WT, Phatak P, Marano CM, et al. Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and unipolar major depression. Psychiatry Res 2007;151:179-188 (Pubitemid 46829420)
81. Wright SJ, Centonze VE, Stricker SA, et al. Introduction to confocal microscopy and three-dimensional reconstruction. Methods Cell Biol 1993;38:1-45
82. Fu Y, Wang HF, Shi RY, Cheng JX. Second harmonic and sum frequency generation imaging of fibrous astroglial filaments in ex vivo spinal tissues. Biophys J 2007;92:3251-3259 (Pubitemid 46684584)
83. Wang H, Huff TB, Fu Y, et al. Increasing the imaging depth of coherent anti-Stokes Raman scattering microscopy with a miniature microscope objective. Opt Lett 2007;32:2212-2214 (Pubitemid 351299487)